Skip to content

Medical-device intelligence

DDC: Thyroglobulin, Antigen, Antiserum, Control

FDA product code DDC: Thyroglobulin, Antigen, Antiserum, Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DDC
FDA device name
Thyroglobulin, Antigen, Antiserum, Control
Device class
2
Regulation number
866.5870
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

13 clearance records and 1 recall records in the covered releases, across 10 source company names and 1 product codes. Dated history runs from Jun 14, 1978 to Oct 26, 2006.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DDC · Thyroglobulin, Antigen, Antiserum, Control131

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

14 matching records
Device / recordCompany in FDA recordSourceSource date
Access Immunoassay Systems Thyroglobulin Antibody Reagent Kit, Part Number 33890Z-0417-2007 · DDCBeckman Coulter IncRecallFeb 7, 2007FDA classification date
SERAQUEST ANTI-THYROGLOBULINK023592 · DDCQuest Intl., Inc.510(k)Jan 6, 2003FDA decision date
ACCESS THYROGLOBULIN ANTIBODY AND CALIBRATORS ON THE ACCESS IMMUNOASSAY SYSTEMS, MODELS 33890, 33895K012208 · DDCBeckman Coulter, Inc.510(k)Sep 7, 2001FDA decision date
MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEMK000363 · DDCZeus Scientific, Inc.510(k)Feb 18, 2000FDA decision date
ZEUS SCIENTIFIC INC., TPO IGG ELISA TEST SYSTEM.K991610 · DDCZeus Scientific, Inc.510(k)Jun 25, 1999FDA decision date
ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEMK991179 · DDCZeus Scientific, Inc.510(k)Jun 17, 1999FDA decision date
ANTI-THYROGLOBULIN (TG) MICROPLATE ELISAK971835 · DDCMonobind510(k)Jul 3, 1997FDA decision date
SERODIA ATGK953066 · DDCFujirebio America, Inc.510(k)Aug 14, 1995FDA decision date
AUTOSTAT II ANTI-THYROGLOBULINK943625 · DDCCogent Diagnotics , Ltd.510(k)Dec 22, 1994FDA decision date
THYROGLOBULIN AUTOANTIBODY ENZYME IMMUNOASSAYK936010 · DDCBiomerica, Inc.510(k)Jul 18, 1994FDA decision date
QUANTA LITE(TM) THYROID T ELISAK930486 · DDCInova Diagnostics, Inc.510(k)Mar 15, 1993FDA decision date
SERA-TEK THYROGLOBULIN ANTIBODY TESTK865020 · DDCMiles Laboratories, Inc.510(k)Feb 2, 1987FDA decision date
THYMUNE-MK780873 · DDCBurroughs Wellcome Co.510(k)Jun 14, 1978FDA decision date
THYMUNE-TK780874 · DDCBurroughs Wellcome Co.510(k)Jun 14, 1978FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗